Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease - PubMed (original) (raw)
Multicenter Study
doi: 10.1038/ki.2012.375. Epub 2012 Dec 19.
Affiliations
- PMID: 23254902
- DOI: 10.1038/ki.2012.375
Free article
Multicenter Study
Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease
Wen Tang et al. Kidney Int. 2013 Mar.
Free article
Abstract
There are few reports regarding outcomes of anti-glomerular basement membrane (GBM) disease in patients who underwent renal replacement therapy. To help define this we studied all patients with anti-GBM disease who started renal replacement therapy for end-stage renal disease (ESRD) in Australia and New Zealand (ANZDATA Registry) between 1963 and 2010 encompassing 449 individuals (0.8 percent of all ESRD patients). The median survival on dialysis was 5.93 years with death predicted by older age and a history of pulmonary hemorrhage. Thirteen patients recovered renal function, although 10 subsequently experienced renal death after a median period of 1.05 years. Of the 224 patients who received their first renal allograft, the 10-year median patient and renal allograft survival rates were 86% and 63%, respectively. Six patients experienced anti-GBM disease recurrence in their allograft, which led to graft failure in two. Using multivariable Cox regression analysis, patients with anti-GBM disease had comparable survival on dialysis or following renal transplantation (hazard ratios of 0.86 and 1.03, respectively) compared to those with ESRD due to other causes. Also, renal allograft survival (hazard ratio of 1.03) was not altered compared to other diseases requiring a renal transplant. Thus, anti-GBM disease was an uncommon cause of ESRD, and not associated with altered risks of dialysis, transplant or first renal allograft survival. Death on dialysis was predicted by older age and a history of pulmonary hemorrhage.
Similar articles
- Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort.
Alchi B, Griffiths M, Sivalingam M, Jayne D, Farrington K. Alchi B, et al. Nephrol Dial Transplant. 2015 May;30(5):814-21. doi: 10.1093/ndt/gfu399. Epub 2015 Jan 20. Nephrol Dial Transplant. 2015. PMID: 25609740 - Clinical features and outcomes of anti-glomerular basement membrane disease in older patients.
Cui Z, Zhao J, Jia XY, Zhu SN, Zhao MH. Cui Z, et al. Am J Kidney Dis. 2011 Apr;57(4):575-82. doi: 10.1053/j.ajkd.2010.09.022. Epub 2010 Dec 18. Am J Kidney Dis. 2011. PMID: 21168945 - End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases.
Mallett A, Tang W, Hart G, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Campbell SB, Clayton PA, Johnson DW. Mallett A, et al. Am J Nephrol. 2015;42(3):177-84. doi: 10.1159/000440815. Epub 2015 Sep 30. Am J Nephrol. 2015. PMID: 26418732 - Outcome of Kidney Transplant in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Buttigieg J, Henderson L, Kidder D. Buttigieg J, et al. Exp Clin Transplant. 2017 Oct;15(5):509-515. doi: 10.6002/ect.2016.0058. Epub 2016 Oct 20. Exp Clin Transplant. 2017. PMID: 27765007 Review.
Cited by
- Drug repurposing for glomerular diseases: an underutilized resource.
Ng MSY, Kaur G, Francis RS, Hawley CM, Johnson DW. Ng MSY, et al. Nat Rev Nephrol. 2024 Jul 31. doi: 10.1038/s41581-024-00864-8. Online ahead of print. Nat Rev Nephrol. 2024. PMID: 39085415 Review. - Goodpasture syndrome: a rare case presenting with recurrent haemoptysis.
Mankuzhy Gopalakrishnan SS, Raveendran R, Paulraj J, Balaganesan H. Mankuzhy Gopalakrishnan SS, et al. BMJ Case Rep. 2024 Jan 3;17(1):e252666. doi: 10.1136/bcr-2022-252666. BMJ Case Rep. 2024. PMID: 38171635 - Atypical Antiglomerular Basement Membrane Disease in a Pregnant Patient with Systemic Lupus Erythematosus.
Ounhasuttiyanon A, Tantranont N, Srithongkul T. Ounhasuttiyanon A, et al. Case Rep Nephrol. 2023 Nov 11;2023:6963543. doi: 10.1155/2023/6963543. eCollection 2023. Case Rep Nephrol. 2023. PMID: 38028131 Free PMC article. - Unleashing the power of complement activation: unraveling renal damage in human anti-glomerular basement membrane disease.
Tang A, Zhao X, Tao T, Xie D, Xu B, Huang Y, Li M. Tang A, et al. Front Immunol. 2023 Sep 15;14:1229806. doi: 10.3389/fimmu.2023.1229806. eCollection 2023. Front Immunol. 2023. PMID: 37781380 Free PMC article. Review. - Clinicopathological characteristics and outcome predictors of anti-glomerular basement membrane glomerulonephritis.
Ge Y, Liu K, Yang G, Yu X, Sun B, Zhang B, Yuan Y, Zeng M, Wang N, Xing C, Mao H. Ge Y, et al. Ren Fail. 2022 Dec;44(1):2037-2045. doi: 10.1080/0886022X.2022.2147673. Ren Fail. 2022. PMID: 36408940 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical